tirzepatide eli lily Lilly's Mounjaro tops other GLP-1s for some type 2 diabetes patients Eli Lilly just issued a

During treatment, periodic follow-up matters more than many people expect

The risk of hypoglycaemia remains low when metformin and GLP-1 receptor agonists are used together without other glucose-lowering medications, as neither typically causes dangerously low blood sugar on their own

Abadier, M., Estevam, J., Berg, D

In both cases, the most common side effects include nausea, vomiting, diarrhoea, stomach pain and bloating

While results in experimental models are promising, research remains preliminary, and findings are not yet conclusive for translational outcomes

Serious Health Risks of Semaglutide Does Semaglutide Cause Cancer